Source: http://uscode.house.gov/view.xhtml?req=(title:42%20section:285a-11%20edition:prelim)
Timestamp: 2019-01-20 11:00:26
Document Index: 378484211

Matched Legal Cases: ['art 1', '§ 285', '§417', '§4', '§101', '§202', '§101', '§121']

[USC04] 42 USC 285a-11: Pediatric cancer research, awareness, and survivorship
<< Previous TITLE 42 / CHAPTER 6A / SUBCHAPTER III / Part C / subpart 1 / § 285a-11 Next >>
42 USC 285a-11: Pediatric cancer research, awareness, and survivorship Text contains those laws in effect on January 19, 2019
(D) Provide access to biospecimens and clinical and demographic data from children, adolescents, and young adults with cancer to researchers and qualified health care professionals for peer-reviewed research-
The Secretary may not make an award under paragraph (1) to an entity unless the Secretary ensures that such entity-
Not later than 4 years after June 5, 2018, the Secretary shall submit to Congress a report on-
The term "biospecimen" includes-
The term "clinical and demographic information" includes-
(E) The identification of, as applicable-
(July 1, 1944, ch. 373, title IV, §417E, as added Pub. L. 110–285, §4(a), July 29, 2008, 122 Stat. 2629 ; amended Pub. L. 115–180, title I, §§101, 102(b), title II, §202, June 5, 2018, 132 Stat. 1383 , 1386, 1389.)
The Minority Health and Health Disparities Research and Education Act of 2000, referred to in subsec. (c), is Pub. L. 106–525, Nov. 22, 2000, 114 Stat. 2495 . For complete classification of this Act to the Code, see Short Title of 2000 Amendments note set out under section 201 of this title and Tables.
2018-Pub. L. 115–180, §101(1), substituted "research, awareness, and survivorship" for "research and awareness" in section catchline.
"(1) Programs of research excellence in pediatric cancer.-The Secretary, in collaboration with the Director of NIH and other Federal agencies with interest in prevention and treatment of pediatric cancer, shall continue to enhance, expand, and intensify pediatric cancer research and other activities related to pediatric cancer, including therapeutically applicable research to generate effective treatments, pediatric preclinical testing, and pediatric clinical trials through National Cancer Institute-supported pediatric cancer clinical trial groups and their member institutions. In enhancing, expanding, and intensifying such research and other activities, the Secretary is encouraged to take into consideration the application of such research and other activities for minority, health disparity, and medically underserved communities. For purposes of this section, the term 'pediatric cancer research' means research on the causes, prevention, diagnosis, recognition, treatment, and long-term effects of pediatric cancer.
"(2) Peer review requirements.-All grants awarded under this subsection shall be awarded in accordance with section 289a of this title."
Pub. L. 115–180, title I, §121, June 5, 2018, 132 Stat. 1387 , provided that: "The Director of the National Institutes of Health shall ensure that childhood cancer research projects conducted or supported by the National Institutes of Health are included in appropriate reports to Congress, which may include the Pediatric Research Initiative report."